iScience (Feb 2022)

miR-376a-3p and miR-376b-3p overexpression in Hutchinson-Gilford progeria fibroblasts inhibits cell proliferation and induces premature senescence

  • Diane Frankel,
  • Valérie Delecourt,
  • Elva-María Novoa-del-Toro,
  • Jérôme D. Robin,
  • Coraline Airault,
  • Catherine Bartoli,
  • Aurélie Carabalona,
  • Sophie Perrin,
  • Kilian Mazaleyrat,
  • Annachiara De Sandre-Giovannoli,
  • Frederique Magdinier,
  • Anaïs Baudot,
  • Nicolas Lévy,
  • Elise Kaspi,
  • Patrice Roll

Journal volume & issue
Vol. 25, no. 2
p. 103757

Abstract

Read online

Summary: Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder, in which an abnormal and toxic protein called progerin, accumulates in cell nuclei, leading to major cellular defects. Among them, chromatin remodeling drives gene expression changes, including miRNA dysregulation. In our study, we evaluated miRNA expression profiles in HGPS and control fibroblasts. We identified an enrichment of overexpressed miRNAs belonging to the 14q32.2-14q32.3 miRNA cluster. Using 3D FISH, we demonstrated that overexpression of these miRNAs is associated with chromatin remodeling at this specific locus in HGPS fibroblasts. We then focused on miR-376b-3p and miR-376a-3p, both overexpressed in HGPS fibroblasts. We demonstrated that their induced overexpression in control fibroblasts decreases cell proliferation and increases senescence, whereas their inhibition in HGPS fibroblasts rescues proliferation defects and senescence and decreases progerin accumulation. By targeting these major processes linked to premature aging, these two miRNAs may play a pivotal role in the pathophysiology of HGPS.

Keywords